Weight Loss Drugs
-
{
- All
- News
- Videos
- Web Stories
-
Can GLP-1 Drugs Cause Sudden Blindness? Nonarteritic Anterior Ischemic Optic Neuropathy Explained
NAION happens when the short posterior ciliary arteries do not provide enough blood and oxygen to the important parts of the optic nerve head.
-
Ozempic-Maker Novo Nordisk Slims Down To 'Novo'
Danish pharmaceuticals giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, announced Monday a name change to just Novo, hoping it will be more...
-
GLP-1s, Muscle And Metabolism: Why Losing Weight Is Not The Same As Becoming Metabolically Healthy
When used appropriately, GLP-1 medicines can be effective. However, wider access also brings risks.
-
Weight Loss Drugs And Hair Loss: New Study Finds Genetic Link In Men
Published online on September 3 in the Journal of Investigative Dermatology, the peer-reviewed study is the first to identify a genetic link between GLP-1 activity and an increased risk of androgenetic alopecia.
-
Ozempic For Cats? Weight-Loss Drugs May Help Overweight Pets
US-based OKAVA Pharmaceuticals started testing a long-acting implant, designed to deliver the medicine continuously for up to six months.
-
China's New Twice-Monthly GLP-1 Shot Helps With Weight Loss In Trails
Bofanglutide, a new biweekly drug, has demonstrated strong efficacy in reducing blood sugar in people with type 2 diabetes.
-
This Simple Blood Test Could Predict Which Weight-Loss Drug Will Work Best For You, Says Study
People with low GIP levels responded best to tirzepatide, regardless of their GLP-1 levels. On the other hand, those with low GLP-1 levels and medium to high GIP levels had the best response to semaglutide.
-
Considering Weight Loss Drugs? 7 Things You Should Know First
Using weight loss drugs is a personal decision that should be made based on informed discussions with healthcare providers and thorough research into the options available.
-
Why Are Indians Quitting Weight-Loss Drugs Despite Lower Prices?
Generic GLP-1 drugs are cheaper than ever, but many Indians aren't staying on treatment. Here's why doctors say retention, not affordability, is the real challenge.
-
America's Most Talked-About Drug Has A Surprising Secret: 69% of GLP-1 Users Are Unlikely To Admit Taking It
While GLP-1 medications have become one of the most visible health trends in America, a report found that less than a third (31%) of current and former GLP-1 users are likely to admit to using one.
-
Ozempic-Mounjaro Paved The Way: 3 New Drugs Likely To Enter Weight Loss Market
Ozempic and Mounjaro are popular weight loss medications that were developed for blood sugar control in individuals with diabetes. Here are the 3 new drugs that are likely to enter the weight loss market as oral GLP-1 drugs.
-
AstraZeneca's Oral GLP-1 Drug Elecoglipron Drives Up To 11.8% Weight Loss In Trial
The positive results come from the Phase 2 VISTA clinical trial, which evaluated elecoglipron in adults with obesity or overweight who also had at least one weight-related health condition.
-
Big Bang Theory's Mayim Bialik's GLP-1 Drug Experience Was A "Nightmare": What Happened
Bialik explained that she did not start taking a GLP-1 drug simply to lose weight. Instead, she hoped it might help with health issues that had affected her for years.
-
Weight Loss Drugs Reduce The Risk Of Breast Cancer By 30%, Finds New Study
Researchers examined health records to compare women who used GLP-1 medications with those who did not. The results showed that women taking these drugs were about 30% less likely to develop breast cancer than women who were not using them.
-
Harvard-Trained Gastroenterologist Reveals What Most People Miss About GLP-1 Drugs
Strap: A Harvard- and Stanford-trained gastroenterologist shares some key facts on GLP-1 drugs that most people often ignore.
-
Can GLP-1 Drugs Cause Sudden Blindness? Nonarteritic Anterior Ischemic Optic Neuropathy Explained
NAION happens when the short posterior ciliary arteries do not provide enough blood and oxygen to the important parts of the optic nerve head.
-
Ozempic-Maker Novo Nordisk Slims Down To 'Novo'
Danish pharmaceuticals giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, announced Monday a name change to just Novo, hoping it will be more...
-
GLP-1s, Muscle And Metabolism: Why Losing Weight Is Not The Same As Becoming Metabolically Healthy
When used appropriately, GLP-1 medicines can be effective. However, wider access also brings risks.
-
Weight Loss Drugs And Hair Loss: New Study Finds Genetic Link In Men
Published online on September 3 in the Journal of Investigative Dermatology, the peer-reviewed study is the first to identify a genetic link between GLP-1 activity and an increased risk of androgenetic alopecia.
-
Ozempic For Cats? Weight-Loss Drugs May Help Overweight Pets
US-based OKAVA Pharmaceuticals started testing a long-acting implant, designed to deliver the medicine continuously for up to six months.
-
China's New Twice-Monthly GLP-1 Shot Helps With Weight Loss In Trails
Bofanglutide, a new biweekly drug, has demonstrated strong efficacy in reducing blood sugar in people with type 2 diabetes.
-
This Simple Blood Test Could Predict Which Weight-Loss Drug Will Work Best For You, Says Study
People with low GIP levels responded best to tirzepatide, regardless of their GLP-1 levels. On the other hand, those with low GLP-1 levels and medium to high GIP levels had the best response to semaglutide.
-
Considering Weight Loss Drugs? 7 Things You Should Know First
Using weight loss drugs is a personal decision that should be made based on informed discussions with healthcare providers and thorough research into the options available.
-
Why Are Indians Quitting Weight-Loss Drugs Despite Lower Prices?
Generic GLP-1 drugs are cheaper than ever, but many Indians aren't staying on treatment. Here's why doctors say retention, not affordability, is the real challenge.
-
America's Most Talked-About Drug Has A Surprising Secret: 69% of GLP-1 Users Are Unlikely To Admit Taking It
While GLP-1 medications have become one of the most visible health trends in America, a report found that less than a third (31%) of current and former GLP-1 users are likely to admit to using one.
-
Ozempic-Mounjaro Paved The Way: 3 New Drugs Likely To Enter Weight Loss Market
Ozempic and Mounjaro are popular weight loss medications that were developed for blood sugar control in individuals with diabetes. Here are the 3 new drugs that are likely to enter the weight loss market as oral GLP-1 drugs.
-
AstraZeneca's Oral GLP-1 Drug Elecoglipron Drives Up To 11.8% Weight Loss In Trial
The positive results come from the Phase 2 VISTA clinical trial, which evaluated elecoglipron in adults with obesity or overweight who also had at least one weight-related health condition.
-
Big Bang Theory's Mayim Bialik's GLP-1 Drug Experience Was A "Nightmare": What Happened
Bialik explained that she did not start taking a GLP-1 drug simply to lose weight. Instead, she hoped it might help with health issues that had affected her for years.
-
Weight Loss Drugs Reduce The Risk Of Breast Cancer By 30%, Finds New Study
Researchers examined health records to compare women who used GLP-1 medications with those who did not. The results showed that women taking these drugs were about 30% less likely to develop breast cancer than women who were not using them.
-
Harvard-Trained Gastroenterologist Reveals What Most People Miss About GLP-1 Drugs
Strap: A Harvard- and Stanford-trained gastroenterologist shares some key facts on GLP-1 drugs that most people often ignore.
